Publication | Open Access
Dose Escalation and Dosimetry of First-in-Human α Radioimmunotherapy with <sup>212</sup>Pb-TCMC-Trastuzumab
125
Citations
21
References
2014
Year
Five dose levels of intraperitoneal (212)Pb-TCMC-trastuzumab treatment of patients with peritoneal carcinomatosis showed little agent-related toxicity, consistent with the dosimetry calculations.
| Year | Citations | |
|---|---|---|
Page 1
Page 1